Background - Corticosteroid use is widespread in recurrent pericarditis, even if rarely indicated, and high doses ( eg, prednisone 1.0 to 1.5 mg . kg(-1) . d(-1)) are generally recommended, although only weak evidence supports their use with possible severe side effects. The aim of this work was to compare side effects, recurrences and other complications, and hospitalizations of a low- versus high- dose regimen of prednisone for recurrent pericarditis. Methods and Results - A retrospective review of all cases of recurrent pericarditis treated with corticosteroids according to different regimens from January 1996 to June 2004 was performed in 2 Italian referral centers. One hundred patients with recurrent pericarditis ( mean age, 50.1 +/- 15.8 years; 57 females) were included in the study; 49 patients ( mean age, 47.5 +/- 16.0; 25 females) were treated with low doses of prednisone ( 0.2 to 0.5 mg . kg (-1) . d(-1)), and 51 patients ( mean age, 52.6 +/- 15.3; 32 females) were treated with prednisone 1.0 mg . kg(-1) . d(-1). Baseline demographic and clinical characteristics were well balanced across the groups. Each initial dose was maintained for 4 weeks and then slowly tapered. After adjustment for potential confounders ( age, female gender, nonidiopathic origin), only high doses of prednisone were associated with severe side effects, recurrences, and hospitalizations ( hazard ratio, 3.61; 95% confidence interval, 1.96 to 6.63; P < 0.001). Conclusions - Use of higher doses of prednisone ( 1.0 mg . kg(-1) . d(-1)) for recurrent pericarditis is associated with more side effects, recurrences, and hospitalizations. Lower doses of prednisone should be considered when corticosteroids are needed to treat pericarditis.

Corticosteroids for Recurrent Pericarditis : High Versus Low Doses: A Nonrandomized Observation / M. Imazio, A. Brucato, D. Cumetti, G. Brambilla, B. Demichelis, S. Ferro, S. Maestroni, E. Cecchi, R. Belli, G. Palmieri, R. Trinchero. - In: CIRCULATION. - ISSN 1524-4539. - 118:6(2008), pp. 667-671.

Corticosteroids for Recurrent Pericarditis : High Versus Low Doses: A Nonrandomized Observation

A. Brucato;
2008

Abstract

Background - Corticosteroid use is widespread in recurrent pericarditis, even if rarely indicated, and high doses ( eg, prednisone 1.0 to 1.5 mg . kg(-1) . d(-1)) are generally recommended, although only weak evidence supports their use with possible severe side effects. The aim of this work was to compare side effects, recurrences and other complications, and hospitalizations of a low- versus high- dose regimen of prednisone for recurrent pericarditis. Methods and Results - A retrospective review of all cases of recurrent pericarditis treated with corticosteroids according to different regimens from January 1996 to June 2004 was performed in 2 Italian referral centers. One hundred patients with recurrent pericarditis ( mean age, 50.1 +/- 15.8 years; 57 females) were included in the study; 49 patients ( mean age, 47.5 +/- 16.0; 25 females) were treated with low doses of prednisone ( 0.2 to 0.5 mg . kg (-1) . d(-1)), and 51 patients ( mean age, 52.6 +/- 15.3; 32 females) were treated with prednisone 1.0 mg . kg(-1) . d(-1). Baseline demographic and clinical characteristics were well balanced across the groups. Each initial dose was maintained for 4 weeks and then slowly tapered. After adjustment for potential confounders ( age, female gender, nonidiopathic origin), only high doses of prednisone were associated with severe side effects, recurrences, and hospitalizations ( hazard ratio, 3.61; 95% confidence interval, 1.96 to 6.63; P < 0.001). Conclusions - Use of higher doses of prednisone ( 1.0 mg . kg(-1) . d(-1)) for recurrent pericarditis is associated with more side effects, recurrences, and hospitalizations. Lower doses of prednisone should be considered when corticosteroids are needed to treat pericarditis.
corticosteroids; pericarditis; pericardium; therapy
Settore MED/09 - Medicina Interna
2008
Article (author)
File in questo prodotto:
File Dimensione Formato  
CIRCULATIONAHA.107.761064.pdf

accesso aperto

Tipologia: Publisher's version/PDF
Dimensione 122.13 kB
Formato Adobe PDF
122.13 kB Adobe PDF Visualizza/Apri
Pubblicazioni consigliate

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/2434/637138
Citazioni
  • ???jsp.display-item.citation.pmc??? 40
  • Scopus 199
  • ???jsp.display-item.citation.isi??? 169
social impact